A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma

Abstract Background Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) require multi‐modality treatment. Immune checkpoint inhibitors (ICIs) are now standard of care in management of recurrent/metastatic HNSCC. However, its role in the definitive and neoadjuvant setting rem...

Full description

Bibliographic Details
Main Authors: Udit Nindra, Joshua Hurwitz, Dion Forstner, Venessa Chin, Richard Gallagher, Jia Liu
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5815

Similar Items